Dmitry Zavlin

Dmitry Zavlin

Auto-generated profile, based on publicly available information

Dmitry Zavlin

Institute for Reconstructive Surgery, Houston Methodist Hospital, Weill Cornell Medicine, Houston, Texas

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Open access
DZDmitry Zavlin
Dmitry Zavlin
KJKevin T. Jubbal
Kevin T. Jubbal
JNJonas G. Noé
Jonas G. Noé
BGBernd Gansbacher
Bernd Gansbacher

14 December 2017 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
EBErica L Bartlett
Erica L Bartlett
DZDmitry Zavlin
Dmitry Zavlin
JFJeffrey D Friedman
Jeffrey D Friedman
AAAariane Abdollahi
Aariane Abdollahi
NRNorman H Rappaport
Norman H Rappaport
With a focus on providing high quality care and reducing facility based expenses there has been an evolution in perioperative care by way of enhanced recovery after surgery (ERAS). ERAS allows for a multidisciplinary and multimodal approach to perioperative care which not only expedites recovery but maximizes patient outcomes. This paradigm shift has been generally accepted by most surgical specialties, including plastic surgery. The goal of this study was to evaluate the impact of ERAS on outcomes in cosmetic plastic surgery. A prospective study consisting of phone call questionnaires was designed where patients from two senior plastic surgeons (N.H.R. and J.D.F.) were followed. The treatment group (n = 10) followed an ERAS protocol while the control group (n = 12) followed the traditional recovery after surgery which included narcotic usage. Patients were contacted on postoperative days (POD) 0 through 7+ and surveyed about a number of outcomes measures. The ERAS group demonstrated a significant reduction in postoperative pain on POD 0, 1, 2, and 3 (all P < 0.01). There was also statistically less nausea/vomiting, fatigue/drowsiness, constipation, and hindrance on ambulation compared to the control group (all P < 0.05). Significance was achieved for reduction in fatigue/drowsiness on POD 0 and 1 (P < 0.01), as well as ability to ambulate on POD 0 and 3 (P = 0.044). Lastly, opioid use (P < 0.001) and constipation (P = 0.003) were decreased. ERAS protocols have demonstrated their importance within multiple surgical fields, including cosmetic plastic surgery. The utility lies in the ability to expedite patient’s recovery while still providing quality care. This study showed a reduction in postoperative complaints by avoiding narcotics without an increase in complications. Our findings signify the importance of ERAS protocols within cosmetic plastic surgery.

22 August 2018 in Burns & Trauma
Verified
Journal Article
Open access
PDF file
DZDmitry Zavlin
Dmitry Zavlin
VCVishwanath Chegireddy
Vishwanath Chegireddy
SBStefanos Boukovalas
Stefanos Boukovalas
ANAnna M. Nia
Anna M. Nia
LBLudwik K. Branski
Ludwik K. Branski
AEAnthony Echo
Anthony Echo
Background: Previous reports individually identified different factors that predict death after burns. The authors employed the multi-center American Burn Association’s (ABA) National Burn Repository (NBR) to elucidate which parameters have the highest negative impact on burn mortality. Methods: We audited data from the NBR v8.0 for the years 2002–2011 and included 137,061 patients in our study. The cases were stratified into two cohorts based on the primary outcome of death/survival and then evaluated for demographic data, intraoperative details, and their morbidity after admission. A multivariable regression analysis aimed to identify independent risk factors associated with mortality. Results: A total of 3.3% of patients in this analysis did not survive their burn injuries. Of those, 52.0% expired within 7 days after admission. Patients in the mortality cohort were of older age (p < 0.001), more frequently female (p < 0.001), and had more pre-existing comorbidities (p < 0.001). Total body surface area (TBSA), inhalation injury, hospitalization time, and occurrence of complications were higher compared to survivors (p < 0.001). Lack of insurance (odds ratio (OR) = 1.84, confidence interval (CI) 1.38–2.46), diabetes (OR = 1.24, CI 1.01–1.53), any complication (OR = 4.09, CI 3.27–5.12), inhalation injury (OR = 3.84, CI 3.38–4.36), and the need for operative procedures (OR = 2.60, CI 2.20–3.08) were the strongest independent contributors to mortality after burns (p < 0.001). Age (OR = 1.07, CI 1.06–1.07) and TBSA (OR = 1.09, CI 1.09–1.09) were significant on a continuous scale (p < 0.001) while overall comorbidities were not a statistical risk factor. Conclusion: Uninsured status, inhalation injury, in-hospital complications, and operative procedures were the strongest mortality predictors after burns. Since most fatal outcomes (52.0%) occur within 7 days after injury, physicians and medical staff need to be aware of these risk factors upon patient admission to a burn center.

2 June 2017 in Microsurgery
Verified
Journal Article
Closed access
PDF file
KJKevin T. Jubbal
Kevin T. Jubbal
DZDmitry Zavlin
Dmitry Zavlin
ASAhmed Suliman
Ahmed Suliman

24 March 2017 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
DZDmitry Zavlin
Dmitry Zavlin
KJKevin T. Jubbal
Kevin T. Jubbal
JFJeffrey D. Friedman
Jeffrey D. Friedman
AEAnthony Echo
Anthony Echo

1 January 2020 in Aesthetic Surgery Journal
Verified
Journal Article
Open access
PDF file
BFBerry Fairchild
Berry Fairchild
WEWarren Ellsworth
Warren Ellsworth
JSJesse C Selber
Jesse C Selber
DBDavid P Bogue
David P Bogue
DZDmitry Zavlin
Dmitry Zavlin
MCMark W Clemens
Mark W Clemens
Traditional 2-stage breast reconstruction involves placement of a textured-surface tissue expander (TTE). Recent studies have demonstrated textured surface devices have higher propensity for bacterial contamination and biofilm formation. The purpose of this study was to evaluate the safety and efficacy of smooth surface tissue expanders (STE) in immediate breast reconstruction. The authors retrospectively reviewed consecutive women who underwent STE breast reconstruction from 2016 to 2017 at 3 institutions. Indications and outcomes were evaluated. A total 112 patients underwent STE reconstruction (75 subpectoral, 37 prepectoral placement), receiving 173 devices and monitored for a mean follow-up of 14.1 months. Demographics of patients included average age of 53 years and average BMI of 27.2 kg/m2, and 18.6% received postmastectomy radiation therapy. Overall complication rates were 15.6% and included mastectomy skin flap necrosis (10.4%), seroma (5.2%), expander malposition (2.9%), and infection requiring intravenous antibiotic therapy (3.5%). Six (3.5%) unplanned reoperations with explantation were reported for 3 infections and 3 patients requesting change of plan with no reconstruction. STEs represent a safe and efficacious alternative to TTE breast reconstruction with at least equitable outcomes. Technique modification including tab fixation, strict pocket control, postoperative bra support, and suture choice may contribute to observed favorable outcomes and are reviewed. Early results for infection control and explantation rate are encouraging and warrant comparative evaluation for potential superiority over TTEs in a prospective randomized trial.